Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

and financial planning. These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in conformity with U.S. GAAP.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2007, and in our periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project. The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, c
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 30, 2014 The evening of ... decades-long heritage in successful medical device development to ... what it takes to successfully innovate in the ... of a two-hour on-site class, Insight gave master’s ... business, McCormick School of Engineering, medical and law ...
(Date:10/31/2014)... The report "Dairy Alternative (Beverage) Market by Type ... Channel (Supermarket, Health Store, Pharmacy, Convenience Store) & ... defines and segments the dairy alternative beverage market ... volume for plant-based dairy alternative beverages. , The ... by 2018 with the Asia-Pacific region as the ...
(Date:10/31/2014)... 2014  Atlanta-based Intellimedix could make a positive ... of Ebola by suggesting a new, computational approach ... Center for Computational Systems Biology have spent years ... uses for existing drugs through systematic repurposing, and ... bout against Ebola. Logo - ...
(Date:10/30/2014)... 30, 2014 2014 Deep Research ... is a professional and in-depth research report on ... Naltrexone HCL information, including its definition, classification, application, ... overview. This research covers the international market analysis, ... industry analysis covering macroeconomic environment & economic situation ...
Breaking Biology Technology:Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 2Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 3Dairy Alternative Beverage Market Projected to Reach $14 Billion by 2018 - Report by MarketsandMarkets 4Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
... the first time observed chemical reactions near absolute zero, ... that reaction rates can be controlled using quantum mechanics, ... results and techniques, described in the Feb. 12 issue ... unknown aspects of how molecules interact, a key to ...
... , CINCINNATI , ... it will release its fourth quarter and full-year 2009 financial results after ... will host a telephone conference call and simultaneous webcast on Thursday, ... and answer session will follow. , Conference Call Instructions ...
... , , , ... /PRNewswire-Asia/ -- The January issue of,"Neuropharmacology", publishes the article ... (MLC 601) protective effects on neuronal and brain,injuries as well ... The French research team was led by Prof. ...
Cached Biology Technology:Seeing the quantum in chemistry: JILA scientists control chemical reactions of ultracold molecules 2Seeing the quantum in chemistry: JILA scientists control chemical reactions of ultracold molecules 3Seeing the quantum in chemistry: JILA scientists control chemical reactions of ultracold molecules 4Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast 2Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast 3Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD 2Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD 3
(Date:10/31/2014)... have uncovered key steps involved in programmed cell death, ... lupus, cancers and neurodegenerative diseases. , The research ... together to discover the three-dimensional structure of a key ... steps in how it causes cell death. Their studies ... and Proceedings of the National Academy of ...
(Date:10/31/2014)... his team have been studying the behavior of ... Alps for years. They observed that ravens slowly ... and playing. However, they also observed that these ... individual. Although in about 50 % of the ... the two affiliating ravens, intervening can be potentially ...
(Date:10/30/2014)... help reduce or reverse soil subsidence and reduce ... Sacramento-San Joaquin River Delta by Dartmouth College researchers ... one of the first to continually measure the ... cycle through wetlands, appears in the journal by ... Worldwide, agricultural drainage of organic soils has resulted ...
Breaking Biology News(10 mins):A matter of life and death: Cell death proteins key to fighting disease 2Dartmouth study finds restoring wetlands can lessen soil sinkage, greenhouse gas emissions 2
... French . , Montreal, October 21, 2009 ... especially fear and disgust, according to a new study published ... As part of the investigation, Olivier Collignon and a team ... et cognition (CERNEC) demonstrated that women are better than men ...
... CHICAGO New research using animal models is ... drug addiction in humans knowledge that may lead ... cravings that cause people to relapse. The findings were ... annual meeting and the world,s largest source of emerging ...
... Atlanta, GA Current research suggests that latent cytomegalovirus ... related report by Onyeagocha et al, "Latent cytomegalovirus infection ... of The American Journal of Pathology . ... the United States. Most people who are infected ...
Cached Biology News:Women outperform men when identifying emotions 2Women outperform men when identifying emotions 3Studies improve knowledge of underlying brain changes caused by addiction 2The bowels of infection 2
AC input: 50-60 Hz230 V...
... arraying proteins of interest with sensitive ... DiscoverLight Protein Array Kits allow for ... lysate or antibody in a low-density ... designed nitrocellulose membranes with a 384-grid ...
... hybridization of DNA or Protein microarrays printed ... glass slides. The proprietary design of the ... flatness, as is often the case with ... (67uL analytical cavity volume) eliminates the need ...
MAb to Myoglobin Cardiac...
Biology Products: